您现在的位置是:【微信950216】新锦江客服网站 > 探索
Weight regain happens 4x faster after stopping GLP
【微信950216】新锦江客服网站2026-02-01 04:02:33【探索】4人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(298)
上一篇: 玉米是胎儿大脑发育的黄金
下一篇: 外国名人故事:贝尔的名人故事 3
相关文章
- 胸怀“国之大者”!“国产化替代”之医药膜破局
- 重生细胞被囚者的牢房清怪顺序 重生细胞被囚者的牢房通关攻略
- Hy hữu: Tờ vé số vứt thùng rác… trúng xổ số miền Nam, bất ngờ phút cuối
- 迪士尼历史最高!《疯狂动物城2》票房超15亿美元
- ทำไมการโจมตีอิหร่านที่อาจเกิดขึ้นโดยสหรัฐฯ ในครั้งนี้จึงอาจแตกต่างออกไปจากครั้งก่อน ๆ
- 神州千食舫手游繁华度怎么提升 繁华度提升方法一览
- 这种停车乱象,终于有人出手了
- 以棋具赋能传承!双龙棋具荣膺女子围甲功勋奖
- 超百G实验成功 中国星地激光通信业务化应用迈上新台阶
- 三国天下归心惊雷连爆队玩法攻略
热门文章
站长推荐
友情链接
- 一个优良兵士的心酸血泪养成史
- 2025环足奖一览:登贝莱再夺一最佳 亚马尔C罗各有收获
- Apink成员尹普美与制作人Rado(黑眼必胜)官宣结婚 结束9年爱情长跑
- 台风“桦加沙”致台湾花莲死亡人数修正为14人
- 独家丨灵心巧手完成年内第5轮融资,红杉中国、CCV参投
- 杜兰特30+7谢泼德18分米切尔16+6 火箭轻取骑士
- 如鸢主线剧情隐藏福利有什么 如鸢主线剧情隐藏福利汇总
- 2021上海市青少年马术场地障碍锦标赛80CM单边贴时计分赛战报
- 宋江豪掷67亿韩元购入首尔圣水洞顶级公寓 与陆星材等艺人为邻
- 崩坏3星际旅情记事簿活动怎么操作 星际旅情记事簿活动攻略
- มทบ.22 จัดพิธีรับศพวีรบุรุษบ้านหนองจานกลับภูมิลำเนา จ.อำนาจเจริญ
- 葛根粉糖糕的功效和做法
- 2024年小学数学智力题及答案(九十四)
- 2025年精选唯美好听的歌词1句
- 室内设计专业学习规划论文
- 历时三年保养维护,秦陵一号铜车马重新面世展出
- 苏州西浦附校迎来第一匹新生马 马术课上有了明星团宠
- 首批交付!合加转型多元化服务模式,拓展环卫专业设备租赁业务
- จนท.ช่วยเหลือ"หมี 3 ตัว
- 四川宜宾市长宁县发生3.1级地震 震源深度12千米







